Medicus Pharma Ltd.
MDCX
$2.17
-$0.05-2.25%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -70.54% | -113.65% | -98.96% | -127.26% | -475.45% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -30.47% | 53.79% | 40.44% | -110.92% | 97.54% |
| Change in Net Operating Assets | -96.90% | -107.81% | -231.60% | -141.21% | 6,335.88% |
| Cash from Operations | -110.19% | -156.16% | -147.43% | -846.47% | -564.73% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -13.00% | 934.50% | 934.50% | 373.98% | 353.21% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 21.14% | 121.21% | 47.16% | 7.05% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.95% | 193.97% | 126.97% | 71.05% | 1,280.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -84.74% | 568.57% | 68.36% | -96.13% | 56,877.24% |